ID   ILF3_HUMAN              Reviewed;         894 AA.
AC   Q12906; A8K6F2; G5E9M5; O43409; Q6P1X1; Q86XY7; Q99544; Q99545; Q9BZH4;
AC   Q9BZH5; Q9NQ95; Q9NQ96; Q9NQ97; Q9NQ98; Q9NQ99; Q9NQA0; Q9NQA1; Q9NQA2;
AC   Q9NRN2; Q9NRN3; Q9NRN4; Q9UMZ9; Q9UN00; Q9UN84; Q9UNA2;
DT   31-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   12-APR-2005, sequence version 3.
DT   18-JUN-2025, entry version 245.
DE   RecName: Full=Interleukin enhancer-binding factor 3;
DE   AltName: Full=Double-stranded RNA-binding protein 76;
DE            Short=DRBP76;
DE   AltName: Full=M-phase phosphoprotein 4;
DE            Short=MPP4;
DE   AltName: Full=Nuclear factor associated with dsRNA;
DE            Short=NFAR;
DE   AltName: Full=Nuclear factor of activated T-cells 90 kDa;
DE            Short=NF-AT-90;
DE   AltName: Full=Translational control protein 80;
DE            Short=TCP80;
GN   Name=ILF3; Synonyms=DRBF, MPHOSPH4, NF90;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   PRELIMINARY NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 19-41;
RP   491-510 AND 555-565.
RC   TISSUE=T-cell lymphoma;
RX   PubMed=7519613; DOI=10.1016/s0021-9258(17)32048-3;
RA   Kao P.N., Chen L., Brock G., Ng J., Kenny J., Smith A.J., Corthesy B.;
RT   "Cloning and expression of cyclosporin A- and FK506-sensitive nuclear
RT   factor of activated T-cells: NF45 and NF90.";
RL   J. Biol. Chem. 269:20691-20699(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND PROTEIN SEQUENCE OF N-TERMINUS.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10400669; DOI=10.1074/jbc.274.29.20432;
RA   Patel R.C., Vestal D.J., Xu Z., Bandyopadhyay S., Guo W., Erme S.M.,
RA   Williams B.R., Sen G.C.;
RT   "DRBP76, a double-stranded RNA-binding nuclear protein, is phosphorylated
RT   by the interferon-induced protein kinase, PKR.";
RL   J. Biol. Chem. 274:20432-20437(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND CHARACTERIZATION.
RC   TISSUE=Liver;
RX   PubMed=10607473; DOI=10.1006/mgme.1999.2934;
RA   Xu Y.-H., Grabowski G.A.;
RT   "Molecular cloning and characterization of a translational inhibitory
RT   protein that binds to coding sequences of human acid beta-glucosidase and
RT   other mRNAs.";
RL   Mol. Genet. Metab. 68:441-454(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1; 2; 4 AND 5), AND
RP   ALTERNATIVE SPLICING.
RC   TISSUE=Melanoma;
RX   PubMed=11167023; DOI=10.1016/s0378-1119(00)00495-9;
RA   Duchange N., Pidoux J., Camus E., Sauvaget D.;
RT   "Alternative splicing in the human interleukin enhancer binding factor 3
RT   (ILF3) gene.";
RL   Gene 261:345-353(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2), AND
RP   CHARACTERIZATION.
RX   PubMed=11438536; DOI=10.1074/jbc.m104207200;
RA   Saunders L.R., Perkins D.J., Balachandran S., Michaels R., Ford R.,
RA   Mayeda A., Barber G.N.;
RT   "Characterization of two evolutionarily conserved, alternatively spliced
RT   nuclear phosphoproteins, NFAR-1 and -2, that function in mRNA processing
RT   and interact with the double-stranded RNA-dependent protein kinase, PKR.";
RL   J. Biol. Chem. 276:32300-32312(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   HIS-50.
RC   TISSUE=T-cell;
RX   PubMed=11161820; DOI=10.1006/geno.2000.6423;
RA   Saunders L.R., Jurecic V., Barber G.N.;
RT   "The 90- and 110-kDa human NFAR proteins are translated from two
RT   differentially spliced mRNAs encoded on chromosome 19p13.";
RL   Genomics 71:256-259(2001).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).
RC   TISSUE=Duodenum, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-611.
RC   TISSUE=Blood, and Cervix;
RX   PubMed=8885239; DOI=10.1091/mbc.7.9.1455;
RA   Matsumoto-Taniura N., Pirollet F., Monroe R., Gerace L., Westendorf J.M.;
RT   "Identification of novel M phase phosphoproteins by expression cloning.";
RL   Mol. Biol. Cell 7:1455-1469(1996).
RN   [12]
RP   PROTEIN SEQUENCE OF 1-10, FUNCTION, AND INTERACTION WITH XRCC6; PRKDC AND
RP   XRCC5.
RX   PubMed=9442054; DOI=10.1074/jbc.273.4.2136;
RA   Ting N.S.Y., Kao P.N., Chan D.W., Lintott L.G., Lees-Miller S.P.;
RT   "DNA-dependent protein kinase interacts with antigen receptor response
RT   element binding proteins NF90 and NF45.";
RL   J. Biol. Chem. 273:2136-2145(1998).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 188-894 (ISOFORMS 1; 2 AND 3).
RA   MacArdle J., Cantarella G.M., Veyrune J.-L., Krasnoselskaya I., Kumar A.;
RT   "Structure and functional characterization of hDRBF gene.";
RL   Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 587-894 (ISOFORM 1).
RC   TISSUE=Brain;
RA   Yu W., Sarginson J., Gibbs R.A.;
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   INTERACTION WITH ILF2.
RX   PubMed=10574923; DOI=10.1074/jbc.274.49.34598;
RA   Satoh M., Shaheen V.M., Kao P.N., Okano T., Shaw M., Yoshida H.,
RA   Richards H.B., Reeves W.H.;
RT   "Autoantibodies define a family of proteins with conserved double-stranded
RT   RNA-binding domains as well as DNA binding activity.";
RL   J. Biol. Chem. 274:34598-34604(1999).
RN   [16]
RP   INTERACTION WITH PRMT1, SUBCELLULAR LOCATION, AND METHYLATION.
RX   PubMed=10749851; DOI=10.1074/jbc.m000023200;
RA   Tang J., Kao P.N., Herschman H.R.;
RT   "Protein-arginine methyltransferase I, the predominant protein-arginine
RT   methyltransferase in cells, interacts with and is regulated by interleukin
RT   enhancer-binding factor 3.";
RL   J. Biol. Chem. 275:19866-19876(2000).
RN   [17]
RP   IDENTIFICATION IN A NUCLEAR EXPORT RECEPTOR COMPLEX WITH XPO5; RAN AND
RP   DOUBLE-STRANDED RNA, AND INTERACTION WITH XPO5.
RX   PubMed=11777942; DOI=10.1083/jcb.200110082;
RA   Brownawell A.M., Macara I.G.;
RT   "Exportin-5, a novel karyopherin, mediates nuclear export of double-
RT   stranded RNA binding proteins.";
RL   J. Cell Biol. 156:53-64(2002).
RN   [18]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=12429849; DOI=10.1091/mbc.e02-05-0271;
RA   Scherl A., Coute Y., Deon C., Calle A., Kindbeiter K., Sanchez J.-C.,
RA   Greco A., Hochstrasser D.F., Diaz J.-J.;
RT   "Functional proteomic analysis of human nucleolus.";
RL   Mol. Biol. Cell 13:4100-4109(2002).
RN   [19]
RP   INTERACTION WITH ILF2.
RX   PubMed=11739746; DOI=10.1128/mcb.22.1.343-356.2002;
RA   Reichman T.W., Muniz L.C., Mathews M.B.;
RT   "The RNA binding protein nuclear factor 90 functions as both a positive and
RT   negative regulator of gene expression in mammalian cells.";
RL   Mol. Cell. Biol. 22:343-356(2002).
RN   [20]
RP   IDENTIFICATION IN A NUCLEAR EXPORT RECEPTOR COMPLEX WITH XPO5; RAN AND VA1
RP   RNA.
RX   PubMed=14570900; DOI=10.1074/jbc.m306808200;
RA   Gwizdek C., Ossareh-Nazari B., Brownawell A.M., Evers S., Macara I.G.,
RA   Dargemont C.;
RT   "Minihelix-containing RNAs mediate exportin-5-dependent nuclear export of
RT   the double-stranded RNA-binding protein ILF3.";
RL   J. Biol. Chem. 279:884-891(2004).
RN   [21]
RP   FUNCTION, INTERACTION WITH DHX36 AND ELAVL1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=14731398; DOI=10.1016/s1097-2765(03)00481-7;
RA   Tran H., Schilling M., Wirbelauer C., Hess D., Nagamine Y.;
RT   "Facilitation of mRNA deadenylation and decay by the exosome-bound, DExH
RT   protein RHAU.";
RL   Mol. Cell 13:101-111(2004).
RN   [22]
RP   IDENTIFICATION IN A NUCLEAR EXPORT RECEPTOR COMPLEX WITH XPO5; RAN; ZNF346
RP   AND DOUBLE-STRANDED RNA, AND INTERACTION WITH XPO5 AND ZNF346.
RX   PubMed=15254228; DOI=10.1128/mcb.24.15.6608-6619.2004;
RA   Chen T., Brownawell A.M., Macara I.G.;
RT   "Nucleocytoplasmic shuttling of JAZ, a new cargo protein for exportin-5.";
RL   Mol. Cell. Biol. 24:6608-6619(2004).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-482 AND THR-592, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-592, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [25]
RP   IDENTIFICATION IN A COMPLEX WITH ILF2; YLPM1; KHDRBS1; RBMX; NCOA5 AND
RP   PPP1CA.
RX   PubMed=17890166; DOI=10.1016/j.bbapap.2007.07.015;
RA   Ulke-Lemee A., Trinkle-Mulcahy L., Chaulk S., Bernstein N.K., Morrice N.,
RA   Glover M., Lamond A.I., Moorhead G.B.G.;
RT   "The nuclear PP1 interacting protein ZAP3 (ZAP) is a putative nucleoside
RT   kinase that complexes with SAM68, CIA, NF110/45, and HNRNP-G.";
RL   Biochim. Biophys. Acta 1774:1339-1350(2007).
RN   [26]
RP   INTERACTION WITH AGO1 AND AGO2.
RX   PubMed=17932509; DOI=10.1038/sj.embor.7401088;
RA   Hoeck J., Weinmann L., Ender C., Ruedel S., Kremmer E., Raabe M.,
RA   Urlaub H., Meister G.;
RT   "Proteomic and functional analysis of Argonaute-containing mRNA-protein
RT   complexes in human cells.";
RL   EMBO Rep. 8:1052-1060(2007).
RN   [27]
RP   IDENTIFICATION IN A MRNP GRANULE COMPLEX, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=17289661; DOI=10.1074/mcp.m600346-mcp200;
RA   Joeson L., Vikesaa J., Krogh A., Nielsen L.K., Hansen T., Borup R.,
RA   Johnsen A.H., Christiansen J., Nielsen F.C.;
RT   "Molecular composition of IMP1 ribonucleoprotein granules.";
RL   Mol. Cell. Proteomics 6:798-811(2007).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-190; SER-792 AND SER-812,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-482 (ISOFORMS 4; 6 AND 7),
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [30]
RP   IDENTIFICATION IN A MRNP COMPLEX, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=19029303; DOI=10.1261/rna.1175909;
RA   Weidensdorfer D., Stoehr N., Baude A., Lederer M., Koehn M., Schierhorn A.,
RA   Buchmeier S., Wahle E., Huettelmaiery S.;
RT   "Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs.";
RL   RNA 15:104-115(2009).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-592 AND SER-792,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-482 (ISOFORMS 4; 6 AND 7),
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [32]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-100 AND LYS-460, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [33]
RP   FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT THR-188 AND THR-315.
RX   PubMed=21123651; DOI=10.1101/gad.1965010;
RA   Harashima A., Guettouche T., Barber G.N.;
RT   "Phosphorylation of the NFAR proteins by the dsRNA-dependent protein kinase
RT   PKR constitutes a novel mechanism of translational regulation and cellular
RT   defense.";
RL   Genes Dev. 24:2640-2653(2010).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62; SER-190; SER-382;
RP   SER-384; SER-482; THR-592 AND SER-812, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [35]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62; SER-190; SER-382;
RP   SER-476; SER-482; THR-592; SER-792 AND SER-812, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [37]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62; SER-382; THR-592; SER-792
RP   AND SER-816, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [38]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62; SER-476; SER-477; SER-482
RP   AND SER-810, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [39]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-348, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [40]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH ILF2.
RX   PubMed=26240280; DOI=10.1128/mcb.00306-15;
RA   Wandrey F., Montellese C., Koos K., Badertscher L., Bammert L., Cook A.G.,
RA   Zemp I., Horvath P., Kutay U.;
RT   "The NF45/NF90 Heterodimer Contributes to the Biogenesis of 60S Ribosomal
RT   Subunits and Influences Nucleolar Morphology.";
RL   Mol. Cell. Biol. 35:3491-3503(2015).
RN   [41]
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=26891316; DOI=10.3390/v8020047;
RA   Li Y., Belshan M.;
RT   "NF45 and NF90 Bind HIV-1 RNA and Modulate HIV Gene Expression.";
RL   Viruses 8:0-0(2016).
RN   [42]
RP   FUNCTION, INTERACTION WITH ILF2, AND SUBCELLULAR LOCATION.
RX   PubMed=28625552; DOI=10.1016/j.molcel.2017.05.023;
RA   Li X., Liu C.X., Xue W., Zhang Y., Jiang S., Yin Q.F., Wei J., Yao R.W.,
RA   Yang L., Chen L.L.;
RT   "Coordinated circRNA Biogenesis and Function with NF90/NF110 in Viral
RT   Infection.";
RL   Mol. Cell 0:0-0(2017).
RN   [43]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-396 AND LYS-489, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [44]
RP   FUNCTION, UBIQUITINATION AT LYS-297, MUTAGENESIS OF LYS-297, AND
RP   INTERACTION WITH HAVCR2.
RX   PubMed=34110282; DOI=10.7554/elife.66501;
RA   Dou S., Li G., Li G., Hou C., Zheng Y., Tang L., Gao Y., Mo R., Li Y.,
RA   Wang R., Shen B., Zhang J., Han G.;
RT   "Ubiquitination and degradation of NF90 by Tim-3 inhibits antiviral innate
RT   immunity.";
RL   Elife 10:0-0(2021).
RN   [45]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 520-594.
RG   Northeast structural genomics consortium (NESG);
RT   "Crystal structure of DRBM 2 domain of interleukin enhancer-binding factor
RT   3 from Homo sapiens, Northeast structural genomics consortium target
RT   HR4527E.";
RL   Submitted (DEC-2010) to the PDB data bank.
RN   [46]
RP   STRUCTURE BY NMR OF 521-600.
RG   Northeast structural genomics consortium (NESG);
RT   "Northeast structural genomics consortium target HR4527E.";
RL   Submitted (SEP-2010) to the PDB data bank.
CC   -!- FUNCTION: RNA-binding protein that plays an essential role in the
CC       biogenesis of circular RNAs (circRNAs) which are produced by back-
CC       splicing circularization of pre-mRNAs. Within the nucleus, promotes
CC       circRNAs processing by stabilizing the regulatory elements residing in
CC       the flanking introns of the circularized exons. Plays thereby a role in
CC       the back-splicing of a subset of circRNAs (PubMed:28625552). As a
CC       consequence, participates in a wide range of transcriptional and post-
CC       transcriptional processes. Binds to poly-U elements and AU-rich
CC       elements (AREs) in the 3'-UTR of target mRNAs (PubMed:14731398). Upon
CC       viral infection, ILF3 accumulates in the cytoplasm and participates in
CC       the innate antiviral response (PubMed:21123651, PubMed:34110282).
CC       Mechanistically, ILF3 becomes phosphorylated and activated by the
CC       double-stranded RNA-activated protein kinase/PKR which releases ILF3
CC       from cellular mature circRNAs. In turn, unbound ILF3 molecules are able
CC       to interact with and thus inhibit viral mRNAs (PubMed:21123651,
CC       PubMed:28625552). {ECO:0000269|PubMed:14731398,
CC       ECO:0000269|PubMed:21123651, ECO:0000269|PubMed:28625552,
CC       ECO:0000269|PubMed:9442054}.
CC   -!- FUNCTION: (Microbial infection) Plays a positive role in HIV-1 virus
CC       production by binding to and thereby stabilizing HIV-1 RNA, together
CC       with ILF3. {ECO:0000269|PubMed:26891316}.
CC   -!- SUBUNIT: Identified in a IGF2BP1-dependent mRNP granule complex
CC       containing untranslated mRNAs. Interacts with FUS and SMN. Interacts
CC       (via C-terminus) with PRMT1. Forms a complex with ILF2. Can also bind
CC       to PRKDC/XRCC7: this may stabilize the interaction of PRKDC/XRCC7 and
CC       the heterodimeric complex of XRCC6/KU70 and XRCC5/KU80. Forms a
CC       heteromeric complex with ZNF346 and ILF3. Found in a nuclear export
CC       complex with XPO5, ILF3, Ran and double-stranded RNA or double-stranded
CC       minihelix VA1 RNA. Found in a nuclear export complex with XPO5, RAN,
CC       ILF3, ZNF346 and double-stranded RNA. Interacts with XPO5 and ZNF346.
CC       Forms a complex with ILF2, YLPM1, KHDRBS1, RBMX, NCOA5 and PPP1CA.
CC       Interacts with AGO1 and AGO2. Interacts with DHX36; this interaction
CC       occurs in a RNA-dependent manner (PubMed:14731398). Interacts with
CC       ELAVL1; this interaction occurs in a RNA-dependent manner
CC       (PubMed:14731398). Interacts with HAVCR2; this interaction promotes
CC       ILF3 ubiquitination and subsequent degradation (PubMed:34110282).
CC       {ECO:0000269|PubMed:10574923, ECO:0000269|PubMed:10749851,
CC       ECO:0000269|PubMed:11739746, ECO:0000269|PubMed:11777942,
CC       ECO:0000269|PubMed:14570900, ECO:0000269|PubMed:14731398,
CC       ECO:0000269|PubMed:15254228, ECO:0000269|PubMed:17289661,
CC       ECO:0000269|PubMed:17890166, ECO:0000269|PubMed:17932509,
CC       ECO:0000269|PubMed:19029303, ECO:0000269|PubMed:26240280,
CC       ECO:0000269|PubMed:28625552, ECO:0000269|PubMed:34110282,
CC       ECO:0000269|PubMed:9442054}.
CC   -!- INTERACTION:
CC       Q12906; P22626: HNRNPA2B1; NbExp=3; IntAct=EBI-78756, EBI-299649;
CC       Q12906; P14866-1: HNRNPL; NbExp=2; IntAct=EBI-78756, EBI-16071645;
CC       Q12906; Q99873: PRMT1; NbExp=4; IntAct=EBI-78756, EBI-78738;
CC       Q12906; P08325: M; Xeno; NbExp=2; IntAct=EBI-78756, EBI-15693250;
CC       Q12906; P03496: NS; Xeno; NbExp=3; IntAct=EBI-78756, EBI-2547442;
CC       Q12906; Q05127: VP35; Xeno; NbExp=6; IntAct=EBI-78756, EBI-6148294;
CC       Q12906-6; Q13148: TARDBP; NbExp=6; IntAct=EBI-12904528, EBI-372899;
CC       Q12906-6; A5D8V6: VPS37C; NbExp=3; IntAct=EBI-12904528, EBI-2559305;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:26240280}.
CC       Cytoplasm {ECO:0000269|PubMed:28625552}. Nucleus
CC       {ECO:0000269|PubMed:10749851, ECO:0000269|PubMed:26240280,
CC       ECO:0000269|PubMed:28625552}. Note=Localizes in the cytoplasm in
CC       response to viral infection. The unphosphorylated form is retained in
CC       the nucleus by ILF2. Phosphorylation at Thr-188 and Thr-315 causes the
CC       dissociation of ILF2 from the ILF2-ILF3 complex resulting in a
CC       cytoplasmic sequestration of ILF3. Localized in cytoplasmic mRNP
CC       granules containing untranslated mRNAs. {ECO:0000269|PubMed:21123651}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1; Synonyms=NFAR-2, ILF3-E;
CC         IsoId=Q12906-1; Sequence=Displayed;
CC       Name=2; Synonyms=NFAR-1, DRBP76;
CC         IsoId=Q12906-2; Sequence=VSP_003888, VSP_003889;
CC       Name=3;
CC         IsoId=Q12906-3; Sequence=VSP_003890, VSP_003891;
CC       Name=4; Synonyms=DRBP76 Alpha, ILF3-A;
CC         IsoId=Q12906-4; Sequence=VSP_003883, VSP_003884, VSP_003885;
CC       Name=5; Synonyms=DRBP76 Delta, Gamma, ILF3-C;
CC         IsoId=Q12906-5; Sequence=VSP_003886, VSP_003887;
CC       Name=6;
CC         IsoId=Q12906-6; Sequence=VSP_003883, VSP_003888, VSP_003889;
CC       Name=7;
CC         IsoId=Q12906-7; Sequence=VSP_003883;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- PTM: Phosphorylated at Thr-188 and Thr-315 by PKR in response to
CC       certain RNA viruses. This phosphorylation results in the dissociation
CC       of ILF2 from the ILF2-ILF3 complex resulting in a cytoplasmic
CC       sequestration of ILF3 where it can bind to viral RNAs and impede viral
CC       replication. {ECO:0000269|PubMed:21123651}.
CC   -!- PTM: Methylated by protein arginine N-methyltransferase 1.
CC       {ECO:0000269|PubMed:10749851}.
CC   -!- PTM: Ubiquitinated at Lys-297 in a TRIM47-dependent manner; this 'Lys-
CC       48'-linked ubiquitination promotes ILF3 degradation.
CC       {ECO:0000269|PubMed:34110282}.
CC   -!- MISCELLANEOUS: [Isoform 3]: Dubious isoform produced through aberrant
CC       splice sites. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA20994.1; Type=Miscellaneous discrepancy; Note=Sequencing errors.; Evidence={ECO:0000305};
CC       Sequence=AAH48314.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U10324; AAA20994.1; ALT_SEQ; mRNA.
DR   EMBL; AF147209; AAD33966.1; -; mRNA.
DR   EMBL; AF141870; AAD37575.1; -; mRNA.
DR   EMBL; AJ271741; CAC01121.1; -; Genomic_DNA.
DR   EMBL; AJ271741; CAC01122.1; -; Genomic_DNA.
DR   EMBL; AJ271741; CAC01123.1; -; Genomic_DNA.
DR   EMBL; AJ271741; CAC01124.1; -; Genomic_DNA.
DR   EMBL; AJ271744; CAC01404.1; -; mRNA.
DR   EMBL; AJ271745; CAC01405.1; -; mRNA.
DR   EMBL; AJ271746; CAC01406.1; -; mRNA.
DR   EMBL; AJ271747; CAC01407.1; -; mRNA.
DR   EMBL; AF167569; AAD51098.1; -; mRNA.
DR   EMBL; AF167570; AAD51099.1; -; mRNA.
DR   EMBL; AF320244; AAK07424.1; -; Genomic_DNA.
DR   EMBL; AF320228; AAK07424.1; JOINED; Genomic_DNA.
DR   EMBL; AF320229; AAK07424.1; JOINED; Genomic_DNA.
DR   EMBL; AF320230; AAK07424.1; JOINED; Genomic_DNA.
DR   EMBL; AF320231; AAK07424.1; JOINED; Genomic_DNA.
DR   EMBL; AF320232; AAK07424.1; JOINED; Genomic_DNA.
DR   EMBL; AF320233; AAK07424.1; JOINED; Genomic_DNA.
DR   EMBL; AF320234; AAK07424.1; JOINED; Genomic_DNA.
DR   EMBL; AF320235; AAK07424.1; JOINED; Genomic_DNA.
DR   EMBL; AF320236; AAK07424.1; JOINED; Genomic_DNA.
DR   EMBL; AF320237; AAK07424.1; JOINED; Genomic_DNA.
DR   EMBL; AF320238; AAK07424.1; JOINED; Genomic_DNA.
DR   EMBL; AF320239; AAK07424.1; JOINED; Genomic_DNA.
DR   EMBL; AF320240; AAK07424.1; JOINED; Genomic_DNA.
DR   EMBL; AF320241; AAK07424.1; JOINED; Genomic_DNA.
DR   EMBL; AF320242; AAK07424.1; JOINED; Genomic_DNA.
DR   EMBL; AF320243; AAK07424.1; JOINED; Genomic_DNA.
DR   EMBL; AF320247; AAK07425.1; -; Genomic_DNA.
DR   EMBL; AF320228; AAK07425.1; JOINED; Genomic_DNA.
DR   EMBL; AF320229; AAK07425.1; JOINED; Genomic_DNA.
DR   EMBL; AF320230; AAK07425.1; JOINED; Genomic_DNA.
DR   EMBL; AF320231; AAK07425.1; JOINED; Genomic_DNA.
DR   EMBL; AF320232; AAK07425.1; JOINED; Genomic_DNA.
DR   EMBL; AF320233; AAK07425.1; JOINED; Genomic_DNA.
DR   EMBL; AF320234; AAK07425.1; JOINED; Genomic_DNA.
DR   EMBL; AF320235; AAK07425.1; JOINED; Genomic_DNA.
DR   EMBL; AF320236; AAK07425.1; JOINED; Genomic_DNA.
DR   EMBL; AF320237; AAK07425.1; JOINED; Genomic_DNA.
DR   EMBL; AF320238; AAK07425.1; JOINED; Genomic_DNA.
DR   EMBL; AF320239; AAK07425.1; JOINED; Genomic_DNA.
DR   EMBL; AF320240; AAK07425.1; JOINED; Genomic_DNA.
DR   EMBL; AF320241; AAK07425.1; JOINED; Genomic_DNA.
DR   EMBL; AF320242; AAK07425.1; JOINED; Genomic_DNA.
DR   EMBL; AF320243; AAK07425.1; JOINED; Genomic_DNA.
DR   EMBL; AF320245; AAK07425.1; JOINED; Genomic_DNA.
DR   EMBL; AF320246; AAK07425.1; JOINED; Genomic_DNA.
DR   EMBL; AK291617; BAF84306.1; -; mRNA.
DR   EMBL; AC011475; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471106; EAW84132.1; -; Genomic_DNA.
DR   EMBL; BC048314; AAH48314.1; ALT_SEQ; mRNA.
DR   EMBL; BC064836; AAH64836.1; -; mRNA.
DR   EMBL; X98264; CAA66917.1; -; mRNA.
DR   EMBL; X98265; CAA66918.1; -; mRNA.
DR   EMBL; AF202445; AAF82685.1; -; Genomic_DNA.
DR   EMBL; AF202445; AAF82686.1; -; Genomic_DNA.
DR   EMBL; AF202445; AAF82687.1; -; Genomic_DNA.
DR   EMBL; AF007140; AAC19152.1; -; mRNA.
DR   CCDS; CCDS12246.1; -. [Q12906-1]
DR   CCDS; CCDS12247.1; -. [Q12906-2]
DR   CCDS; CCDS45965.1; -. [Q12906-7]
DR   CCDS; CCDS45966.1; -. [Q12906-5]
DR   CCDS; CCDS45967.1; -. [Q12906-6]
DR   PIR; B54857; B54857.
DR   RefSeq; NP_001131145.1; NM_001137673.2. [Q12906-6]
DR   RefSeq; NP_001381737.1; NM_001394808.1. [Q12906-7]
DR   RefSeq; NP_001381738.1; NM_001394809.1. [Q12906-7]
DR   RefSeq; NP_001381739.1; NM_001394810.1. [Q12906-7]
DR   RefSeq; NP_001381740.1; NM_001394811.1. [Q12906-1]
DR   RefSeq; NP_001381741.1; NM_001394812.1. [Q12906-1]
DR   RefSeq; NP_001381750.1; NM_001394821.1. [Q12906-6]
DR   RefSeq; NP_001381751.1; NM_001394822.1. [Q12906-6]
DR   RefSeq; NP_001381752.1; NM_001394823.1. [Q12906-6]
DR   RefSeq; NP_001381753.1; NM_001394824.1. [Q12906-2]
DR   RefSeq; NP_001381755.1; NM_001394826.1. [Q12906-2]
DR   RefSeq; NP_004507.2; NM_004516.3. [Q12906-2]
DR   RefSeq; NP_036350.2; NM_012218.3. [Q12906-1]
DR   RefSeq; NP_060090.2; NM_017620.2. [Q12906-7]
DR   RefSeq; NP_703194.1; NM_153464.3. [Q12906-5]
DR   RefSeq; XP_011526286.2; XM_011527984.2.
DR   RefSeq; XP_016882252.1; XM_017026763.1.
DR   RefSeq; XP_047294734.1; XM_047438778.1. [Q12906-7]
DR   RefSeq; XP_047294735.1; XM_047438779.1. [Q12906-7]
DR   RefSeq; XP_054176869.1; XM_054320894.1. [Q12906-7]
DR   RefSeq; XP_054176870.1; XM_054320895.1. [Q12906-7]
DR   PDB; 2L33; NMR; -; A=521-600.
DR   PDB; 3P1X; X-ray; 1.90 A; A/B=520-594.
DR   PDB; 7RJM; X-ray; 2.10 A; C=99-106.
DR   PDB; 7RJQ; X-ray; 1.72 A; B=99-106.
DR   PDBsum; 2L33; -.
DR   PDBsum; 3P1X; -.
DR   PDBsum; 7RJM; -.
DR   PDBsum; 7RJQ; -.
DR   AlphaFoldDB; Q12906; -.
DR   SMR; Q12906; -.
DR   BioGRID; 109822; 923.
DR   CORUM; Q12906; -.
DR   DIP; DIP-29853N; -.
DR   FunCoup; Q12906; 3460.
DR   IntAct; Q12906; 734.
DR   MINT; Q12906; -.
DR   STRING; 9606.ENSP00000404121; -.
DR   BindingDB; Q12906; -.
DR   ChEMBL; CHEMBL5465305; -.
DR   GlyGen; Q12906; 3 sites, 1 O-linked glycan (3 sites).
DR   iPTMnet; Q12906; -.
DR   MetOSite; Q12906; -.
DR   PhosphoSitePlus; Q12906; -.
DR   SwissPalm; Q12906; -.
DR   BioMuta; ILF3; -.
DR   DMDM; 62512150; -.
DR   CPTAC; CPTAC-395; -.
DR   CPTAC; CPTAC-396; -.
DR   jPOST; Q12906; -.
DR   MassIVE; Q12906; -.
DR   PaxDb; 9606-ENSP00000404121; -.
DR   PeptideAtlas; Q12906; -.
DR   ProteomicsDB; 33984; -.
DR   ProteomicsDB; 59014; -. [Q12906-1]
DR   ProteomicsDB; 59015; -. [Q12906-2]
DR   ProteomicsDB; 59016; -. [Q12906-3]
DR   ProteomicsDB; 59017; -. [Q12906-4]
DR   ProteomicsDB; 59018; -. [Q12906-5]
DR   ProteomicsDB; 59019; -. [Q12906-6]
DR   Pumba; Q12906; -.
DR   TopDownProteomics; Q12906-1; -. [Q12906-1]
DR   Antibodypedia; 1051; 363 antibodies from 36 providers.
DR   DNASU; 3609; -.
DR   Ensembl; ENST00000250241.12; ENSP00000250241.8; ENSG00000129351.18. [Q12906-5]
DR   Ensembl; ENST00000407004.8; ENSP00000384660.2; ENSG00000129351.18. [Q12906-6]
DR   Ensembl; ENST00000588657.6; ENSP00000468181.1; ENSG00000129351.18. [Q12906-7]
DR   Ensembl; ENST00000589998.6; ENSP00000465219.1; ENSG00000129351.18. [Q12906-2]
DR   Ensembl; ENST00000590261.5; ENSP00000468156.1; ENSG00000129351.18. [Q12906-1]
DR   Ensembl; ENST00000592763.5; ENSP00000465515.1; ENSG00000129351.18. [Q12906-4]
DR   GeneID; 3609; -.
DR   KEGG; hsa:3609; -.
DR   MANE-Select; ENST00000588657.6; ENSP00000468181.1; NM_017620.3; NP_060090.2. [Q12906-7]
DR   UCSC; uc002mpl.3; human. [Q12906-1]
DR   AGR; HGNC:6038; -.
DR   CTD; 3609; -.
DR   DisGeNET; 3609; -.
DR   GeneCards; ILF3; -.
DR   HGNC; HGNC:6038; ILF3.
DR   HPA; ENSG00000129351; Low tissue specificity.
DR   MIM; 603182; gene.
DR   OpenTargets; ENSG00000129351; -.
DR   VEuPathDB; HostDB:ENSG00000129351; -.
DR   eggNOG; KOG3792; Eukaryota.
DR   GeneTree; ENSGT00940000156719; -.
DR   HOGENOM; CLU_015490_0_0_1; -.
DR   InParanoid; Q12906; -.
DR   OMA; PANHTQY; -.
DR   OrthoDB; 8898434at2759; -.
DR   PAN-GO; Q12906; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; Q12906; -.
DR   PathwayCommons; Q12906; -.
DR   Reactome; R-HSA-9762293; Regulation of CDH11 gene transcription.
DR   Reactome; R-HSA-9833482; PKR-mediated signaling.
DR   SignaLink; Q12906; -.
DR   SIGNOR; Q12906; -.
DR   BioGRID-ORCS; 3609; 672 hits in 1165 CRISPR screens.
DR   CD-CODE; 232F8A39; P-body.
DR   CD-CODE; 804901D1; Nuclear speckle.
DR   CD-CODE; 91857CE7; Nucleolus.
DR   CD-CODE; DEE660B4; Stress granule.
DR   CD-CODE; F85A2E29; IMP1 RNP granule.
DR   ChiTaRS; ILF3; human.
DR   EvolutionaryTrace; Q12906; -.
DR   GeneWiki; ILF3; -.
DR   GenomeRNAi; 3609; -.
DR   Pharos; Q12906; Tbio.
DR   PRO; PR:Q12906; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q12906; protein.
DR   Bgee; ENSG00000129351; Expressed in ganglionic eminence and 207 other cell types or tissues.
DR   ExpressionAtlas; Q12906; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; HDA:BHF-UCL.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB.
DR   GO; GO:0035925; F:mRNA 3'-UTR AU-rich region binding; IDA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003727; F:single-stranded RNA binding; IBA:GO_Central.
DR   GO; GO:0001618; F:virus receptor activity; IDA:UniProt.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:0017148; P:negative regulation of translation; ISS:UniProtKB.
DR   GO; GO:0045071; P:negative regulation of viral genome replication; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0160091; P:spliceosome-depend formation of circular RNA; IDA:UniProtKB.
DR   CDD; cd19910; DSRM_ILF3_rpt1; 1.
DR   CDD; cd19912; DSRM_ILF3_rpt2; 1.
DR   FunFam; 1.10.1410.40:FF:000001; interleukin enhancer-binding factor 3 isoform X1; 1.
DR   FunFam; 3.30.160.20:FF:000006; interleukin enhancer-binding factor 3 isoform X2; 1.
DR   FunFam; 3.30.160.20:FF:000008; interleukin enhancer-binding factor 3 isoform X2; 1.
DR   Gene3D; 1.10.1410.40; -; 1.
DR   Gene3D; 3.30.160.20; -; 2.
DR   Gene3D; 3.30.460.10; Beta Polymerase, domain 2; 2.
DR   InterPro; IPR014720; dsRBD_dom.
DR   InterPro; IPR033099; DSRM1_ILF3.
DR   InterPro; IPR006561; DZF_dom.
DR   InterPro; IPR049402; DZF_dom_C.
DR   InterPro; IPR049401; DZF_dom_N.
DR   InterPro; IPR043519; NT_sf.
DR   PANTHER; PTHR45762:SF4; INTERLEUKIN ENHANCER-BINDING FACTOR 3; 1.
DR   PANTHER; PTHR45762; ZINC FINGER RNA-BINDING PROTEIN; 1.
DR   Pfam; PF00035; dsrm; 2.
DR   Pfam; PF20965; DZF_C; 1.
DR   Pfam; PF07528; DZF_N; 1.
DR   SMART; SM00358; DSRM; 2.
DR   SMART; SM00572; DZF; 1.
DR   SUPFAM; SSF54768; dsRNA-binding domain-like; 2.
DR   PROSITE; PS50137; DS_RBD; 2.
DR   PROSITE; PS51703; DZF; 1.
DR   neXtProt; NX_Q12906; -.
DR   PharmGKB; PA29853; -.
DR   TreeFam; TF320194; -.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Antiviral defense;
KW   Cytoplasm; Direct protein sequencing; DNA-binding; Isopeptide bond;
KW   Methylation; Nucleus; Phosphoprotein; Proteomics identification;
KW   Reference proteome; Repeat; RNA-binding; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..894
FT                   /note="Interleukin enhancer-binding factor 3"
FT                   /id="PRO_0000126070"
FT   DOMAIN          5..378
FT                   /note="DZF"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01040"
FT   DOMAIN          398..467
FT                   /note="DRBM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00266"
FT   DOMAIN          524..590
FT                   /note="DRBM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00266"
FT   REGION          50..86
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          363..401
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          466..524
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          609..894
FT                   /note="Interaction with PRMT1"
FT                   /evidence="ECO:0000269|PubMed:10749851"
FT   REGION          625..660
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          718..894
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           371..389
FT                   /note="Bipartite nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        60..73
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        74..86
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        372..383
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        472..481
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        489..508
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        644..660
FT                   /note="Gly residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        743..770
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        777..792
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        811..825
FT                   /note="Gly residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        832..851
FT                   /note="Gly residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        857..866
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        867..878
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         62
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         100
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         188
FT                   /note="Phosphothreonine; by PKR"
FT                   /evidence="ECO:0000269|PubMed:21123651"
FT   MOD_RES         190
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692"
FT   MOD_RES         315
FT                   /note="Phosphothreonine; by PKR"
FT                   /evidence="ECO:0000269|PubMed:21123651"
FT   MOD_RES         382
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         384
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         460
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         476
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         477
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         482
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         592
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:17081983, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         792
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         810
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         812
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692"
FT   MOD_RES         816
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   CROSSLNK        297
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:34110282"
FT   CROSSLNK        348
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0007744|PubMed:25114211"
FT   CROSSLNK        396
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        489
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         516
FT                   /note="E -> ENVKQ (in isoform 4, isoform 6 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:11167023,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_003883"
FT   VAR_SEQ         687..690
FT                   /note="SQFY -> TGFV (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:11167023"
FT                   /id="VSP_003886"
FT   VAR_SEQ         688..702
FT                   /note="QFYSNGGHSGNASGG -> DFFTDCYGYHDFGSS (in isoform 2 and
FT                   isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:10400669,
FT                   ECO:0000303|PubMed:11161820, ECO:0000303|PubMed:11167023,
FT                   ECO:0000303|PubMed:11438536, ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.13"
FT                   /id="VSP_003888"
FT   VAR_SEQ         688..694
FT                   /note="QFYSNGG -> KCAFLSV (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:11167023"
FT                   /id="VSP_003884"
FT   VAR_SEQ         690..764
FT                   /note="YSNGGHSGNASGGGGGGGGGSSGYGSYYQGDNYNSPVPPKHAGKKQPHGGQQ
FT                   KPSYGSGYQSHQGQQQSYNQSPY -> SRPPPPSRPRCCVVRCSGSPCGPSCDPYLAVF
FT                   GTPCLQWFVSCHYNFVWVEFLSFCSSVSLCLFTLRVSGNSVCL (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10607473, ECO:0000303|Ref.13"
FT                   /id="VSP_003890"
FT   VAR_SEQ         691..894
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:11167023"
FT                   /id="VSP_003887"
FT   VAR_SEQ         695..894
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:11167023"
FT                   /id="VSP_003885"
FT   VAR_SEQ         703..894
FT                   /note="Missing (in isoform 2 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:10400669,
FT                   ECO:0000303|PubMed:11161820, ECO:0000303|PubMed:11167023,
FT                   ECO:0000303|PubMed:11438536, ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.13"
FT                   /id="VSP_003889"
FT   VAR_SEQ         765..894
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10607473, ECO:0000303|Ref.13"
FT                   /id="VSP_003891"
FT   VARIANT         50
FT                   /note="D -> H (in dbSNP:rs1064493)"
FT                   /evidence="ECO:0000269|PubMed:11161820"
FT                   /id="VAR_022159"
FT   VARIANT         501
FT                   /note="A -> S (in dbSNP:rs34520379)"
FT                   /id="VAR_048906"
FT   CONFLICT        101
FT                   /note="G -> C (in Ref. 5; AAD51098/AAD51099 and 6;
FT                   AAK07424/AAK07425)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        260
FT                   /note="G -> V (in Ref. 2; AAD33966 and 11; CAA66918)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        647
FT                   /note="S -> T (in Ref. 2; AAD33966 and 6;
FT                   AAK07424/AAK07425)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        688..689
FT                   /note="QF -> N (in Ref. 13; AAF82687)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        763
FT                   /note="P -> L (in Ref. 4; CAC01407)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        797
FT                   /note="G -> R (in Ref. 4; CAC01124 and 6; AAK07425)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        799
FT                   /note="S -> SGS (in Ref. 13; AAF82685)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        813
FT                   /note="G -> E (in Ref. 6; AAK07425)"
FT                   /evidence="ECO:0000305"
FT   HELIX           102..104
FT                   /evidence="ECO:0007829|PDB:7RJQ"
FT   HELIX           528..535
FT                   /evidence="ECO:0007829|PDB:3P1X"
FT   STRAND          541..548
FT                   /evidence="ECO:0007829|PDB:3P1X"
FT   STRAND          554..561
FT                   /evidence="ECO:0007829|PDB:3P1X"
FT   STRAND          564..572
FT                   /evidence="ECO:0007829|PDB:3P1X"
FT   HELIX           573..588
FT                   /evidence="ECO:0007829|PDB:3P1X"
FT   MOD_RES         Q12906-4:482
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332"
FT   MOD_RES         Q12906-6:482
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332"
FT   MOD_RES         Q12906-7:482
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332"
SQ   SEQUENCE   894 AA;  95338 MW;  20903ABD0331F370 CRC64;
     MRPMRIFVND DRHVMAKHSS VYPTQEELEA VQNMVSHTER ALKAVSDWID EQEKGSSEQA
     ESDNMDVPPE DDSKEGAGEQ KTEHMTRTLR GVMRVGLVAK GLLLKGDLDL ELVLLCKEKP
     TTALLDKVAD NLAIQLAAVT EDKYEILQSV DDAAIVIKNT KEPPLSLTIH LTSPVVREEM
     EKVLAGETLS VNDPPDVLDR QKCLAALASL RHAKWFQARA NGLKSCVIVI RVLRDLCTRV
     PTWGPLRGWP LELLCEKSIG TANRPMGAGE ALRRVLECLA SGIVMPDGSG IYDPCEKEAT
     DAIGHLDRQQ REDITQSAQH ALRLAAFGQL HKVLGMDPLP SKMPKKPKNE NPVDYTVQIP
     PSTTYAITPM KRPMEEDGEE KSPSKKKKKI QKKEEKAEPP QAMNALMRLN QLKPGLQYKL
     VSQTGPVHAP IFTMSVEVDG NSFEASGPSK KTAKLHVAVK VLQDMGLPTG AEGRDSSKGE
     DSAEETEAKP AVVAPAPVVE AVSTPSAAFP SDATAEQGPI LTKHGKNPVM ELNEKRRGLK
     YELISETGGS HDKRFVMEVE VDGQKFQGAG SNKKVAKAYA ALAALEKLFP DTPLALDANK
     KKRAPVPVRG GPKFAAKPHN PGFGMGGPMH NEVPPPPNLR GRGRGGSIRG RGRGRGFGGA
     NHGGYMNAGA GYGSYGYGGN SATAGYSQFY SNGGHSGNAS GGGGGGGGGS SGYGSYYQGD
     NYNSPVPPKH AGKKQPHGGQ QKPSYGSGYQ SHQGQQQSYN QSPYSNYGPP QGKQKGYNHG
     QGSYSYSNSY NSPGGGGGSD YNYESKFNYS GSGGRSGGNS YGSGGASYNP GSHGGYGGGS
     GGGSSYQGKQ GGYSQSNYNS PGSGQNYSGP PSSYQSSQGG YGRNADHSMN YQYR
//
